Bottom line
RYCEX vs VGK: the short answer
RYCEX (Europe 1.25x Strategy Fund) and VGK (Vanguard European Stock Index Fund) are both mutual funds.
But VGK is far broader, holding 1,245 positions to 56 for RYCEX, so beyond the top names it adds exposure RYCEX doesn't have.
VGK is cheaper at 0.06% vs 2.36% — a difference of $230 a year per $10,000 invested.
Over five years, VGK returned +10.1% a year vs +9.0% for RYCEX.
Updated Nov 19, 2026
RYCEX vs VGK side by side
| RYCEX | VGK | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | Vanguard |
| Category | Single Country / Region | Single Country / Region |
| Expense ratio | 2.36% | 0.06% |
| Annual cost per $10k | $236 | $6 |
| 10-yr cost on $10k (prospectus) | $2,889 | $77 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +30.7% | +35.4% |
| 5-yr return (annualized) | +9.0% | +10.1% |
| 10-yr return (annualized) | +6.5% | +8.7% |
| Best quarter | +26.6% | +21.1% |
| Worst quarter | −27.6% | −25.7% |
| Net assets (fund) | $2.1M | $38.5B |
| Number of holdings | 56 | 1,245 |
| Portfolio turnover | 1,775% | 5% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYCEX | VGK | Difference |
|---|---|---|---|
| 2025 | +31.7% | +35.4% | −3.8% |
| 2024 | −3.3% | +2.0% | −5.3% |
| 2023 | +18.6% | +20.0% | −1.4% |
| 2022 | −13.5% | −16.0% | +2.5% |
| 2021 | +17.8% | +16.4% | +1.5% |
| 2020 | −0.3% | +6.5% | −6.8% |
| 2019 | +28.9% | +24.3% | +4.6% |
| 2018 | −19.4% | −14.8% | −4.6% |
Source: Fund prospectus bar charts
Holdings overlap
3 of RYCEX's top 25 holdings also appear in VGK's top 25.
| Holding | RYCEX | VGK |
|---|---|---|
| Astrazeneca Plc | 1.52% | 1.59% |
| Totalenergies Se | 0.92% | 1.05% |
| Ubs Group Ag | 0.79% | 1.03% |
Source: SEC Form N-PORT
RYCEX top 10
- J.p. Morgan Securities Llc — 22.36%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 22.36%
- Asml Holding Nv — 3.99%
- Guggenheim Funds Trust — 3.37%
- Guggenheim Funds Trust — 3.27%
- Hsbc Holdings Plc — 1.68%
- Novartis Ag — 1.54%
- Astrazeneca Plc — 1.52%
- Roche Holding Ag — 1.49%
- Nestle' Sa/ag — 1.37%
VGK top 10
- ASML Holding NV — 3.95%
- HSBC Holdings PLC — 2.27%
- Roche Holding AG — 1.91%
- Novartis AG — 1.81%
- Nestle SA — 1.60%
- AstraZeneca PLC — 1.59%
- Siemens AG — 1.49%
- Shell PLC — 1.46%
- Banco Santander SA — 1.28%
- Allianz SE — 1.18%
FAQ
What is the difference between RYCEX and VGK?
Which is cheaper, RYCEX or VGK?
Should I own both RYCEX and VGK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.